The two-day Global Partnership on Artificial Intelligence (GPAI) Summit was held in Belgrade, gathering around 1,000 participants from 45 countries worldwide. The Global Partnership on Artificial Intelligence is a leading international organization focused on the development, implementation, and regulation of artificial intelligence. The organization was founded in 2020, and Serbia became a member two years later.
The summit, organized by the National Assembly of the Republic of Serbia, the Government of the Republic of Serbia, the Ministry of Science, Technological Development and Innovation, the Office for IT and e-Government, and the United Nations Development Programme, featured a panel titled “AI-Powered Diagnostics: Transforming Healthcare with Biotech Innovations,” organized by Prof. Dr. Nenad Filipović, Acting Director of the Science Fund of the Republic of Serbia.
The panel discussed the impact of artificial intelligence (AI) on the transformation of medicine, particularly in the fields of diagnostics, disease prediction and prevention, personalized patient treatments, and data collection and analysis. Panelists discussed how AI is changing the way we recognize diseases and develop therapeutic approaches, improving patient outcomes and shaping modern medicine. The discussion also touched on the regulatory framework for AI development in healthcare and the differences in regulations between the United States and Europe, which significantly impact the pace of AI development in different countries.
The keynote speaker of the panel was Prof. Dr. Howard Moskowitz, founder of Mind Genomics Associates, known for his pioneering work in human preference research and the application of AI in biomedical studies. Moskowitz focuses on the use of AI in personalizing treatments based on scientific data about patient preferences.
Other panel participants included:
– Dr. Dimitrios Fotiadis, Professor of Biomedical Engineering at the University of Ioannina, Greece
– Dr. Christian Guttman, President and Executive Founder of the Nordic Artificial Intelligence Institute, Lecturer at the Karolinska Institute, Sweden
– Dr. Nikola Vitković, Head of Information Systems at the Faculty of Mechanical Engineering, University of Niš
– Dr. Zoran Obradović, Professor and Director of the Center for Data Analysis and Biomedical Informatics at Temple University, USA
The panelists discussed the opportunities AI offers in medicine, such as automated patient triage systems, AI applications in sepsis diagnostics, and the use of AI in emergency calls and crisis situations. The discussion emphasized that AI should be seen as an assistant to healthcare workers, helping them make timely, precise, and fair decisions. Additionally, challenges related to regulations that guide the development of AI in healthcare were addressed. It was highlighted that it is crucial for countries to have clear and transparent regulations that not only enable faster technological development but also ensure patient data security and protection. Only with such regulations can AI reach its full potential in healthcare, providing better healthcare for all. The panelists also reflected on the development of AI in Serbia, where a strategy for AI development over the next five years has already been established.
